They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...

"This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and ...

Dr Reddy's Laboratories has received approval to manufacture and market generic semaglutide, a weight loss drug, once Novo Nordisk's patent expires in 2026.

The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...

In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...

At least 2,000 pens labelled as containing tirzepatide and retatrutide were seized along with tens of thousands of empty pens ...

Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.

Analysts believe that while the deal is positive, Cipla's share price is unlikely to see a fresh run-up, given the rise it ...

LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity ...